Jagiellonian University Repository

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Relapsed/Refractory Multiple Myeloma Patients Treated With Lenalidomide : a Pharmacogenetic Study From the IMMEnSE Consortium

pcg.skipToMenu

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Relapsed/Refractory Multiple Myeloma Patients Treated With Lenalidomide : a Pharmacogenetic Study From the IMMEnSE Consortium

Bibliographic description

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)